Company: SATT
Filing Date: 2025-08-15
Form Type: 10-Q
Source: 0001683168-25-006219
Chunk: 6

Company: SATIVUS TECH CORP.
Filing Date: 2025-08-15
Form: 10-Q
Item: Item 1
Chunk 6
---
 the Company formed a new wholly-owned subsidiary in Israel, Hachevra Legiduley Pkaot Beisrael Ltd. (the “New Subsidiary”), to develop a fully automated and remotely managed system for growing saffron and other vegetables. On November 5, 2020, the New Subsidiary changed its name to Saffron-Tech Ltd. (or “Saffron Tech”). As of the date of this report, and following various financings in Saffron Tech, the Company owns 54% of Saffron Tech.

    The Company, through Saffron Tech, is focusing
    on its in-house research and development of agriculture technology products, among others, in the fields of exotic plants and mushrooms.
    Saffron Tech plans to roll out its proof of concept in the coming months. This technology will provide turnkey automated growing containers
    for high-quality, high-yield saffron all year round. The Company is in advanced stages of developing and testing a fully automated and
    remotely managed system for growing high-quality, high-yield saffron anywhere and anytime.
     
    It is also environmentally friendly, using economic
    levels of water, space, fertilizer, and energy. Accounting to the Company’s calculations, we believe that the controlled indoor
    growing area will produce ten times more yield compared to the same land area using traditional methods. The sealed environment eliminates
    the need for harmful pesticides and herbicides, producing a clean and safe product that is easy to control from anywhere. The Company’s
    solution is easily scalable and pre-designed to quickly grow operations.
     
    Saffron is used in many industries, such as the
    food industry, particularly by famous chefs and Michelin starred restaurants, the natural cosmetics industry and the food supplements
    industry and as a dye in the textile industry. Medicinal claims as an anti-depressant, antioxidant, and antiseptic are constantly increasing.

    b.
    The Company has an accumulated deficit in the total amount of $23,941 as of June 30, 2025, the Company has negative operating cash flow in the total amount of $86 for the three months ended June 30, 2025, further losses are anticipated in the development of its business. Those factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company obtaining the necessary financing to meet its obligations